US Patent 8158156 | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Actavis Inc

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Actavis Inc

VISIT THE VIRTUAL BOOTH, Contact Details

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

DIGITAL CONTENT

INTERVIEW #SpeakPharma, VLOG #PharmaReel, DATA COMPILATION #PharmaFlow, 413 NEWS #PharmaBuzz

INTERVIEW #SpeakPharma
VLOG #PharmaReel
DATA COMPILATION #PharmaFlow
413 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

108 All APIs, 104 USDMF, 7 CEP/COS, 1 JDMF, 3 EU WC, 5 NDC API, 1 VMF

108 All APIs
104 USDMF
7 CEP/COS
1 JDMF
3 EU WC
5 NDC API
1 VMF

FINISHED DOSAGE FORMULATIONS

3584 FDF Dossiers, 2334 FDA Orange Book, 1219 Europe, 2 Australia, 29 South Africa

3584 FDF Dossiers
2334 FDA Orange Book
1219 Europe
2 Australia
29 South Africa

EXCIPIENTS

1 All Excipients, 1 USDMF

1 All Excipients
1 USDMF

INSPECTIONS & REGISTRATIONS

76 FDA, 31 EDQM, 14 GDUFA

76 FDA
31 EDQM
14 GDUFA

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

6 All

01 6ALPHARMA PHARMS

filter Patent Number Reset all filters

6 All

01 68158156

filter API Patent Reset all filters

6 All

01 6Blank

filter FDF Patent Reset all filters

6 All

01 6Blank

filter Expiration Date Reset all filters

6 All

01 62027-06-19

01

ALPHARMA PHARMS

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

PharmScience R&D

Not Confirmed

ALPHARMA PHARMS

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-19

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

US Patent Number : 8158156

Drug Substance Claim :

Drug Product Claim :

Application Number : 22321

Patent Use Code : U-1510

Delist Requested :

Patent Use Description : MANAGEMENT OF PAIN SEV...

Patent Expiration Date : 2027-06-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

ALPHARMA PHARMS

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

PharmScience R&D

Not Confirmed

ALPHARMA PHARMS

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-19

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

US Patent Number : 8158156

Drug Substance Claim :

Drug Product Claim :

Application Number : 22321

Patent Use Code : U-1510

Delist Requested :

Patent Use Description : MANAGEMENT OF PAIN SEV...

Patent Expiration Date : 2027-06-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

ALPHARMA PHARMS

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

PharmScience R&D

Not Confirmed

ALPHARMA PHARMS

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-19

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

US Patent Number : 8158156

Drug Substance Claim :

Drug Product Claim :

Application Number : 22321

Patent Use Code : U-1510

Delist Requested :

Patent Use Description : MANAGEMENT OF PAIN SEV...

Patent Expiration Date : 2027-06-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

ALPHARMA PHARMS

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

PharmScience R&D

Not Confirmed

ALPHARMA PHARMS

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-19

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

US Patent Number : 8158156

Drug Substance Claim :

Drug Product Claim :

Application Number : 22321

Patent Use Code : U-1510

Delist Requested :

Patent Use Description : MANAGEMENT OF PAIN SEV...

Patent Expiration Date : 2027-06-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

ALPHARMA PHARMS

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

PharmScience R&D

Not Confirmed

ALPHARMA PHARMS

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-19

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

US Patent Number : 8158156

Drug Substance Claim :

Drug Product Claim :

Application Number : 22321

Patent Use Code : U-1510

Delist Requested :

Patent Use Description : MANAGEMENT OF PAIN SEV...

Patent Expiration Date : 2027-06-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

ALPHARMA PHARMS

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

PharmScience R&D

Not Confirmed

ALPHARMA PHARMS

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-19

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

US Patent Number : 8158156

Drug Substance Claim :

Drug Product Claim :

Application Number : 22321

Patent Use Code : U-1510

Delist Requested :

Patent Use Description : MANAGEMENT OF PAIN SEV...

Patent Expiration Date : 2027-06-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!